Please provide your email address to receive an email when new articles are posted on . Sulcus placement is more technically difficult but preserves endothelial cells. Consider factors such as eye ...

Glaucoma is the second most common cause of blindness in the United States and worldwide. [1,2] It is a progressive optic neuropathy characterized by nerve atrophy and loss of retinal ganglion cells.

Trabeculectomy as a first-line procedure to treat glaucoma is more cost-effective than tube shunt surgery for people with elevated intraocular pressure (IOP), but tube shunt surgery may be the better ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO —Trabeculectomy with mitomycin C had a higher success rate than tube shunt surgery in patients with ...

Surgery is considered when medications aren’t enough to treat glaucoma. Surgical options include trabeculectomy, tube shunt implantation, MIGS, and cyclophotocoagulation, each of which aims to lower ...

(HealthDay)—For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are ...

Reviewed by Sarju Patel, MD MPH MSc, Director of Uveitis and Ocular Immunology, Assistant Professor of Ophthalmology, Weill Cornell Medical College, New York, NY Primary open angle glaucoma is ...

Glaucoma, a vision impairment caused by a buildup of pressure in the eye, affects more than 2 million Americans, with millions more at risk. Surgical treatments for hard-to-control cases include the ...

CAMPBELL, Calif., Jan. 26, 2026 /PRNewswire/ -- Myra Vision, a Shifamed portfolio company, today announced the first patient enrolled in its ADAPT clinical study evaluating the Calibreye™ TGT Surgical ...